Presentation TCT 2021 Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk Presenter: Joanna Chikwe November 05, 2021 REGISTER for free or LOG IN to view this content Structural Heart TCT 2021 Mitral Valve Up Next Presentation TCT 2021 Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More) Presenter: Ori Ben-Yehuda November 05, 2021 More slides + Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021 Presentation TCT 2021 CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure Presenter: Mohamed Abdel-Wahab November 05, 2021 We Recommend Disclosures Nothing to disclose
Presentation TCT 2021 Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More) Presenter: Ori Ben-Yehuda November 05, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
Presentation TCT 2021 CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure Presenter: Mohamed Abdel-Wahab November 05, 2021